542 related articles for article (PubMed ID: 29860457)
21. Outcome of "treat and monitor" regimen of aflibercept and ranibizumab in macular edema secondary to non-ischemic branch retinal vein occlusion.
Pichi F; Elbarky AM; Elhamaky TR
Int Ophthalmol; 2019 Jan; 39(1):145-153. PubMed ID: 29274022
[TBL] [Abstract][Full Text] [Related]
22. Reading speed improvements in retinal vein occlusion after ranibizumab treatment.
Suñer IJ; Bressler NM; Varma R; Lee P; Dolan CM; Ward J; Colman S; Rubio RG
JAMA Ophthalmol; 2013 Jul; 131(7):851-6. PubMed ID: 23699977
[TBL] [Abstract][Full Text] [Related]
23. Treatment of Retinal Vein Occlusion with Ranibizumab in Clinical Practice: Longer-Term Results and Predictive Factors of Functional Outcome.
Farinha C; Marques JP; Almeida E; Baltar A; Santos AR; Melo P; Costa M; Figueira J; Cachulo ML; Pires I; Silva R
Ophthalmic Res; 2015; 55(1):10-8. PubMed ID: 26540281
[TBL] [Abstract][Full Text] [Related]
24. Ranibizumab and aflibercept intravitreal injection for treatment naïve and refractory macular oedema in branch retinal vein occlusion.
Hogg HJ; Di Simplicio S; Pearce MS
Eur J Ophthalmol; 2021 Mar; 31(2):548-555. PubMed ID: 32009462
[TBL] [Abstract][Full Text] [Related]
25. Comparison between ranibizumab and aflibercept for macular edema associated with central retinal vein occlusion.
Saishin Y; Ito Y; Fujikawa M; Sawada T; Ohji M
Jpn J Ophthalmol; 2017 Jan; 61(1):67-73. PubMed ID: 27660163
[TBL] [Abstract][Full Text] [Related]
26. Optical Coherence Tomography Angiography of DME and Its Association with Anti-VEGF Treatment Response.
Lee J; Moon BG; Cho AR; Yoon YH
Ophthalmology; 2016 Nov; 123(11):2368-2375. PubMed ID: 27613201
[TBL] [Abstract][Full Text] [Related]
27. Response to aflibercept as secondary therapy in patients with persistent retinal edema due to central retinal vein occlusion initially treated with bevacizumab or ranibizumab.
Eadie JA; Ip MS; Kulkarni AD
Retina; 2014 Dec; 34(12):2439-43. PubMed ID: 24999721
[TBL] [Abstract][Full Text] [Related]
28. Macular function following intravitreal ranibizumab for macular edema associated with branch retinal vein occlusion: 12-month results.
Nishimura T; Machida S; Tada A; Oshida E; Muto T
Doc Ophthalmol; 2020 Oct; 141(2):127-136. PubMed ID: 32100140
[TBL] [Abstract][Full Text] [Related]
29. Month 24 Outcomes After Treatment Initiation With Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: SCORE2 Report 10: A Secondary Analysis of the SCORE2 Randomized Clinical Trial.
Scott IU; Oden NL; VanVeldhuisen PC; Ip MS; Blodi BA; Chan CK;
JAMA Ophthalmol; 2019 Dec; 137(12):1389-1398. PubMed ID: 31600368
[TBL] [Abstract][Full Text] [Related]
30. Antivascular endothelial growth factors in the treatment of macular oedema secondary to central retinal vein occlusion: a meta-analysis.
Zhou S; Gao J; Xu X
Clin Exp Ophthalmol; 2014; 42(7):637-49. PubMed ID: 24330277
[TBL] [Abstract][Full Text] [Related]
31. Optical coherence tomography angiography analysis of macular vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy.
Sorour OA; Sabrosa AS; Yasin Alibhai A; Arya M; Ishibazawa A; Witkin AJ; Baumal CR; Duker JS; Waheed NK
Int Ophthalmol; 2019 Oct; 39(10):2361-2371. PubMed ID: 31119505
[TBL] [Abstract][Full Text] [Related]
32. Optical coherence tomography angiography in retinal vein occlusion treated with dexamethasone implant: a new test for follow-up evaluation.
Glacet-Bernard A; Sellam A; Coscas F; Coscas G; Souied EH
Eur J Ophthalmol; 2016 Aug; 26(5):460-8. PubMed ID: 27405288
[TBL] [Abstract][Full Text] [Related]
33. Quantitative Analysis of Retinal Microvascular Changes after Conbercept Therapy in Branch Retinal Vein Occlusion Using Optical Coherence Tomography Angiography.
Deng Y; Cai X; Zhang S; Su L; Chen H; Lin Y; Sun L; Chen G; Zhong L; Jin C; Chi W
Ophthalmologica; 2019; 242(2):69-80. PubMed ID: 31112969
[TBL] [Abstract][Full Text] [Related]
34. QUALITATIVE AND QUANTITATIVE FOLLOW-UP USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF RETINAL VEIN OCCLUSION TREATED WITH ANTI-VEGF: Optical Coherence Tomography Angiography Follow-up of Retinal Vein Occlusion.
Sellam A; Glacet-Bernard A; Coscas F; Miere A; Coscas G; Souied EH
Retina; 2017 Jun; 37(6):1176-1184. PubMed ID: 27685676
[TBL] [Abstract][Full Text] [Related]
35. Macular function following intravitreal ranibizumab for macular edema associated with branch retinal vein occlusion.
Nishimura T; Machida S; Tada A; Oshida E; Muto T
Doc Ophthalmol; 2019 Aug; 139(1):67-74. PubMed ID: 30980231
[TBL] [Abstract][Full Text] [Related]
36. The short-term efficacy of intravitreal ranibizumab, aflibercept and dexamethasone implant in the treatment of macular edema due to non-ischemic central retinal vein occlusion.
Yucel OE; Birinci H; Sullu Y
Int Ophthalmol; 2019 Apr; 39(4):891-901. PubMed ID: 29550932
[TBL] [Abstract][Full Text] [Related]
37. SCORE2 Report 2: Study Design and Baseline Characteristics.
Scott IU; VanVeldhuisen PC; Ip MS; Blodi BA; Oden NL; Figueroa M; Dugel PU;
Ophthalmology; 2017 Feb; 124(2):245-256. PubMed ID: 27863843
[TBL] [Abstract][Full Text] [Related]
38. Time to clinically significant visual acuity gains after ranibizumab treatment for retinal vein occlusion: BRAVO and CRUISE trials.
Thach AB; Yau L; Hoang C; Tuomi L
Ophthalmology; 2014 May; 121(5):1059-66. PubMed ID: 24424249
[TBL] [Abstract][Full Text] [Related]
39. Effect of aflibercept on persistent macular edema secondary to central retinal vein occlusion.
Kaya F; Kocak I; Aydin A; Baybora H; Koc H; Karabela Y
J Fr Ophtalmol; 2018 Nov; 41(9):809-813. PubMed ID: 30361176
[TBL] [Abstract][Full Text] [Related]
40. Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes.
Puche N; Glacet A; Mimoun G; Zourdani A; Coscas G; Soubrane G
Acta Ophthalmol; 2012 Jun; 90(4):357-61. PubMed ID: 20602625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
